Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E37.84 EPS (ttm)0.97 Insider Own0.50% Shs Outstand2.60B Perf Week-1.08%
Market Cap94.93B Forward P/E20.80 EPS next Y1.76 Insider Trans0.00% Shs Float2.52B Perf Month-4.39%
Income2.45B PEG2.87 EPS next Q0.78 Inst Own18.30% Short Float0.48% Perf Quarter-6.97%
Sales21.45B P/S4.43 EPS this Y-13.40% Inst Trans0.20% Short Ratio2.45 Perf Half Y-1.30%
Book/sh4.71 P/B7.76 EPS next Y3.84% ROA3.90% Target Price43.04 Perf Year4.22%
Cash/sh1.63 P/C22.45 EPS next 5Y13.20% ROE18.50% 52W Range32.69 - 41.78 Perf YTD-3.77%
Dividend1.40 P/FCF- EPS past 5Y-13.50% ROI13.30% 52W High-12.51% Beta0.58
Dividend %3.83% Quick Ratio0.70 Sales past 5Y-4.30% Gross Margin79.50% 52W Low11.81% ATR0.77
Employees61100 Current Ratio0.90 Sales Q/Q-14.30% Oper. Margin14.00% RSI (14)40.67 Volatility1.63% 1.79%
OptionableYes Debt/Eq1.75 EPS Q/Q-37.20% Profit Margin11.30% Rel Volume0.93 Prev Close36.29
ShortableYes LT Debt/Eq1.54 EarningsFeb 07 BMO Payout141.60% Avg Volume4.98M Price36.55
Recom1.70 SMA20-2.53% SMA50-5.95% SMA200-2.84% Volume4,646,331 Change0.72%
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Aug-16-18Downgrade Jefferies Buy → Hold
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
May-12-17Upgrade Credit Suisse Underperform → Neutral
Apr-10-17Downgrade Jefferies Buy → Hold
Apr-05-17Downgrade UBS Buy → Neutral
Mar-09-17Initiated Liberum Buy
Dec-09-16Upgrade Leerink Partners Mkt Perform → Outperform
Jan-18-19 09:11AM  Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY Zacks
06:41AM  Immunomedics Gets CRL From FDA for Breast Cancer Candidate Zacks
Jan-17-19 09:30AM  NVS or AZN: Which Is the Better Value Stock Right Now? Zacks
Jan-16-19 10:05AM  Ironwood's (IRWD) Linzess Gets Approval in China for IBS-C Zacks
06:25AM  BRIEF-Luye Pharma Reaches Strategic Partnership With Astrazeneca, Strengthens Commitment To Cardiovascular Therapeutic Field Reuters
Jan-15-19 07:14PM  BRIEF-Luye Pharma Announces Grant Of Promotion Right Of Xuezhikang Capsules In China To Astrazeneca Reuters
Jan-14-19 05:52PM  Pharma Stocks Topple After House Dems Launch Drug-Pricing Probe Investor's Business Daily
12:09PM  House Democrats launch drug-pricing probe into a dozen major health-care companies CNBC
11:57AM  Sell Amarin Stock on the Recent Takeover Rumors Rally InvestorPlace
10:22AM  Can Inovio Pharmaceuticals Stock Keep Bounding Higher? Motley Fool
08:39AM  What's in Store for Merck in 2019 After a Solid Run in '18? Zacks
04:24AM  AstraZeneca Departures Continue as Medical Chief Bohen Exits Bloomberg
Jan-10-19 04:38PM  Astrazeneca lays off 210 as it closes drug manufacturing plants in Boulder, Longmont American City Business Journals
05:00AM  Top Picks 2019- AstraZeneca PLC AZN MoneyShow
Jan-09-19 07:02PM  MoCo economic development officials plan satellite office in Boston American City Business Journals
10:04AM  Moderna (MRNA) Announces Pipeline Progress, Shares Rise Zacks
Jan-07-19 08:14PM  [$$] AstraZeneca Appoints Controversial Cancer Doctor to Head Research Unit The Wall Street Journal
02:28PM  AstraZeneca hires former Sloan Kettering specialist to lead oncology R&D unit American City Business Journals
10:34AM  AstraZeneca picks Baselga to lead oncology R&D in growth plan Reuters
09:50AM  Ironwood to Get New CEO, Current CEO to Head Latest Spinoff Zacks
09:31AM  AstraZeneca picks Baselga to lead oncology R&D in growth plan Reuters
09:28AM  [$$] AstraZeneca Appoints Controversial Cancer Doctor to Head Research Unit The Wall Street Journal
09:27AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
08:30AM  AstraZeneca appoints Baselga to head R&D for oncology Reuters
02:07AM  Sosei Heptares to Receive US$15 Million Milestone Payment From AstraZeneca With First Partnered Program Moving Towards Phase 2 PR Newswire
Jan-06-19 10:50PM  [$$] AstraZeneca hires controversial head of cancer R&D Financial Times
Jan-04-19 07:08PM  Ironwood Pharmaceuticals Picks AstraZeneca Executive to Be Next CEO The Wall Street Journal
12:29PM  Ironwood co-founder, CEO will step down to head new spinout American City Business Journals
11:01AM  Ironwood Pharmaceuticals Picks AstraZeneca Executive to Be Next CEO The Wall Street Journal
10:07AM  Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate Zacks
Jan-03-19 10:10AM  Why the Earnings Surprise Streak Could Continue for Astrazeneca (AZN) Zacks
Jan-02-19 04:27PM  Could This New Biotech IPO Could Score Big With A Cancer Vaccine? Investor's Business Daily
09:35AM  U.K. Manufacturers Step Up Stockpiling as Brexit Looms Bloomberg
Jan-01-19 06:22AM  What Should You Know About The Future Of AstraZeneca PLCs (LON:AZN)? Simply Wall St.
Dec-30-18 03:27PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
Dec-27-18 06:06PM  Immunomedics Enters Into Supply Deal for Breast Cancer Drug Zacks
08:20AM  Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019 Zacks
Dec-24-18 09:53AM  Health Care Digest: 'Killing off' the JPM Week golden goose, a $75 million complement and more American City Business Journals
08:07AM  The Zacks Analyst Blog Highlights: Procter & Gamble, Oracle, United Parcel Service, FedEx and AstraZeneca Zacks
Dec-21-18 01:36PM  Top Research Reports for Procter & Gamble, Oracle & United Parcel Service Zacks
09:13AM  Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations Zacks
Dec-20-18 05:34PM  AstraZeneca's (AZN) Lynparza Gets FDA Nod in 1st Line Setting Zacks
04:14PM  Can This Biotech Stock Rival Amgen In Anemia? Analyst Says Yes Investor's Business Daily
02:24PM  [$$] Big Pharma Wins Drug Approval in China Ahead of West for First Time The Wall Street Journal
09:09AM  AstraZeneca stock up 2.8% after announcing EU approval of COPD treatment MarketWatch
08:38AM  Myriad Genetics' New FDA Nod for BRACAnalysis CDx Widens Base Zacks
07:00AM  Phase III OLYMPUS and ROCKIES Trials for roxadustat Met Their Primary Endpoints in Chronic Kidney Disease Patients With Anemia Business Wire
03:02AM  AstraZeneca's ovarian cancer and anaemia treatments meet goals in late-stage studies Reuters
02:57AM  AstraZeneca's ovarian cancer and anemia treatments meet goals in late-stage studies Reuters
02:52AM  [$$] Pharma Giants Plan Drug Price Hike: Report The Wall Street Journal
Dec-19-18 07:48PM  Exclusive: Big Pharma returning to U.S. price hikes in January after pause Reuters
04:38PM  AstraZeneca's ovarian cancer drug gets FDA nod as maintenance treatment Reuters
04:01PM  LYNPARZA® (olaparib) Approved by US FDA for First-Line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer Business Wire
Dec-18-18 08:21PM  [$$] Big Pharma Wins Drug Approval in China Ahead of West for First Time The Wall Street Journal
05:18PM  Why a kidney disease drug approval in China is just the start for this S.F. company American City Business Journals
09:30AM  BMY vs. AZN: Which Stock Should Value Investors Buy Now? Zacks
06:24AM  China first to approve AstraZeneca, FibroGen anaemia drug Reuters
Dec-17-18 03:22PM  Merck to Acquire Europe's Antelliq Group for $2.4 Billion Zacks
07:00AM  Pyramid Biosciences Announces Exclusive Global License of AstraZeneca TRK Program for Dermatology and Inflammatory Diseases PR Newswire
Dec-14-18 08:19AM  Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus Zacks
Dec-13-18 12:15PM  Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi GlobeNewswire
03:17AM  Edited Transcript of AZN.L earnings conference call or presentation 26-Jul-18 11:30am GMT Thomson Reuters StreetEvents
Dec-12-18 01:07AM  Here is What Hedge Funds Think About AstraZeneca plc (AZN) Insider Monkey
Dec-11-18 12:42PM  Gabelli Names Clovis As Top Pick, Calls The Biotech A Likely Takeout Candidate Benzinga
10:26AM  Moderna Stock Ushers In the Next Wave of Biotech InvestorPlace
07:19AM  Can Moderna Stock Recover From Its Initial Setback? Motley Fool
Dec-08-18 08:09PM  Is Bristol Myers Squibb Co. (BMY) A Good Stock To Buy According To Hedge Funds? Insider Monkey
Dec-07-18 04:11PM  New Biotech IPO Dropped a Unicorn-Sized Value on Its First Day Bloomberg
02:55AM  AstraZeneca's Imfinzi fails to meet main goals in head and neck cancer study Reuters
Dec-05-18 10:18PM  Here's Why Agenus Stock Popped 51.6% in November Motley Fool
09:49AM  Inovio (INO) to Receive Milestone Payment From AstraZeneca Zacks
07:48AM  GlaxoSmithKline Capital Inc. -- Moody's changes GSK's outlook to negative; affirms A2 ratings Moody's
07:00AM  Today's Research Reports on Trending Tickers: Eli Lilly and Company and AstraZeneca ACCESSWIRE
12:00AM  [$$] Repeat offender companies warned of fresh investor onslaught Financial Times
Dec-04-18 08:27AM  Glaxo to Buy Zejula Maker TESARO for $5.1B, Stock Down 8% Zacks
08:06AM  TESARO Shares Rally on Glaxo's $5.1 Billion Buyout Offer Zacks
Dec-03-18 01:45PM  New Long-Term Data on CALQUENCE Presented at ASH 2018 Business Wire
06:41AM  [$$] Stocks to watch: GSK, RPC, Stobart, Ted Baker, Bodycote, Tesaro Financial Times
Nov-29-18 04:05PM  Moderna IPO On Path To Be Largest Offering Of Venture-Backed Biotech Investor's Business Daily
02:30AM  Biocartis partners with AstraZeneca on lung cancer diagnostics Reuters
01:39AM  Biocartis partners with AstraZeneca on lung cancer diagnostics Reuters
01:01AM  Biocartis Group NV: Biocartis and AstraZeneca Enter Into Agreement Aimed at Faster Lung Cancer Biomarker Results GlobeNewswire
12:17AM  AstraZeneca PLC (LON:AZN): The Best Of Both Worlds Simply Wall St.
Nov-28-18 08:16AM  3 Top Dividend Stocks to Buy Right Now Motley Fool
Nov-27-18 07:51PM  [$$] Drugmakers Gain More Access to China, but at a Price The Wall Street Journal
10:39AM  Astrazeneca's Fasenra Gets Orphan Drug for Autoimmune Disease Zacks
07:00AM  AstraZeneca Presents Clinical Research Advances for Blood Cancer Patients at 2018 American Society of Hematology Annual Meeting Business Wire
Nov-26-18 09:23AM  The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca Zacks
Nov-23-18 08:58AM  Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs Zacks
07:18AM  Read This Before You Buy AstraZeneca PLC (LON:AZN) Because Of Its P/E Ratio Simply Wall St.
Nov-22-18 09:30AM  BMY vs. AZN: Which Stock Is the Better Value Option? Zacks
Nov-21-18 09:02AM  Clovis' (CLVS) Rubraca Gets Another US Patent, Shares Up Zacks
08:58AM  TESARO Shares Rally on Rumors of Potential Acquisition Offer Zacks
08:16AM  Can Deal Interest Help Tesaro Recover? Motley Fool
Nov-20-18 08:12AM  Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails Zacks
07:00AM  Today's Research Reports on Trending Tickers: AstraZeneca and AbbVie ACCESSWIRE
Nov-19-18 02:33PM  Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta Zacks
09:49AM  AstraZeneca's Imfinzi Fails in Lung Cancer Study, Stock Down Zacks
Nov-16-18 09:39AM  Stocks Slide At Open; This Dow Jones Name Bucks Chip Sell Off Investor's Business Daily
08:35AM  Pharma Stock Roundup: FDA Updates on MRK, AZN's Cancer Drugs, Bayer's Q3 Earnings Zacks
AstraZeneca PLC discovers, develops, and commercializes prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, gastrointestinal, neuroscience, and infection diseases worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL4, Tenormin5, and Zestril6 for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo4 for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. AstraZeneca PLC has a strategic partnership with Bicycle Therapeutics; and with Biothera Pharmaceuticals, Inc. to evaluate cancer related drugs, as well as has a collaboration agreement with Innate Pharma S.A. for oncology development. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC has clinical collaboration with Immunomedics, Inc. for the development of Imfinzi(R) and sacituzumab govitecan combination therapy, to include second-line metastatic non-small cell lung cancer. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASTRAZENECA PLC10% OwnerOct 22Buy5.00600,0003,000,0003,004,554Oct 24 04:16 PM
ASTRAZENECA PLC10% OwnerSep 28Buy15.00246,6663,699,9902,164,855Oct 02 09:35 PM